Overview
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Description
This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .
Eligibility
Inclusion Criteria:
- Written informed consent
- Male
- not pregnant female
- patients >=60 years old
- Diagnosis of acute leukemia
Exclusion Criteria:
- Pregnancy
- HIV positive
- patients >=100 years old